Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | MIP-1A | 27.0 | 59 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | MIP-1A | 24.0 | 63 | |
RA2159 | EO1428 | 1.0 | uM | 3 | MIP-1A | 16.0 | 65 | ||||
N2586 | TNF-a | 100 | ng/mL | 3 | MIP-1A | 40.0 | 69 | ||||
N2586 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 3 | MIP-1A | 31.0 | 66 | |
N2586 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | MIP-1A | 39.0 | 65 | |
N2586 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | MIP-1A | 15.0 | 59 | |
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | MIP-1A | 22.5 | 62 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | MIP-1A | 37.0 | 57 | |
N2586 | EO1428 | 1.0 | uM | 3 | MIP-1A | 17.0 | 60 | ||||
0 | MIP-1A | 13.5 | 54 | ||||||||
RA2159 | 3 | MIP-1A | 14.5 | 62 | |||||||
RA2159 | PD184352 | 0.1 | uM | 3 | MIP-1A | 16.0 | 58 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 3 | MIP-1A | 15.0 | 76 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 3 | MIP-1A | 16.5 | 64 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 3 | MIP-1A | 15.0 | 49 | ||||
RA2159 | IKK16 | 2.0 | uM | 3 | MIP-1A | 17.0 | 72 | ||||
RA2159 | 3 | MIP-1A | 19.0 | 58 | |||||||
N2586 | 3 | MIP-1A | 19.0 | 69 | |||||||
N2586 | PD184352 | 0.1 | uM | 3 | MIP-1A | 16.5 | 50 | ||||
N2586 | Lestaurtinib | 0.3 | uM | 3 | MIP-1A | 18.5 | 64 | ||||
N2586 | Ruxolitinib | 0.3 | uM | 3 | MIP-1A | 15.5 | 50 | ||||
N2586 | Tofacitinib | 0.3 | uM | 3 | MIP-1A | 15.0 | 37 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | MIP-1A | 18.0 | 58 | ||||
N2586 | 3 | MIP-1A | 16.0 | 29 |